Syros Pharmaceuticals Management

Management Kriterienprüfungen 2/4

Syros Pharmaceuticals' CEO is Conley Chee, appointed in Dec 2023, has a tenure of less than a year. total yearly compensation is $1.04M, comprised of 46% salary and 54% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth $277.47K. The average tenure of the management team and the board of directors is 2.6 years and 11.6 years respectively.

Wichtige Informationen

Conley Chee

Geschäftsführender

US$1.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts46.0%
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführers0.5%
Durchschnittliche Amtszeit des Managements2.6yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder11.6yrs

Jüngste Management Updates

Recent updates

Syros Pharmaceuticals: Entering A Decisive Era With An Expected 2024 Phase 3 Readout

Jul 02

Syros Pharmaceuticals: Rising Despite Dilution, A Must Look

Jan 14

Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders

Sep 20

Syros gets FDA orphan drug designation for pancreatic cancer treatment SY-5609

Sep 13

Syros Pharmaceuticals Q2 2022 Earnings Preview

Aug 08

Syros Pharmaceuticals Is A Buy As New Trials Start

Nov 20

Syros Pharmaceuticals (NASDAQ:SYRS) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Nov 08
Syros Pharmaceuticals (NASDAQ:SYRS) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Conley Chee im Vergleich zu den Einnahmen von Syros Pharmaceuticals verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

-US$98m

Jun 30 2024n/an/a

-US$132m

Mar 31 2024n/an/a

-US$144m

Dec 31 2023US$1mUS$479k

-US$165m

Vergütung im Vergleich zum Markt: Conley's total compensation ($USD1.04M) is above average for companies of similar size in the US market ($USD655.65K).

Entschädigung vs. Einkommen: Insufficient data to compare Conley's compensation with company performance.


Geschäftsführer

Conley Chee (54 yo)

less than a year

Amtszeit

US$1,041,697

Vergütung

Mr. Conley Chee serves as President, Chief Executive Officer & Director at Syros Pharmaceuticals, Inc. since December 02, 2023. He served as Chief Commercial Officer at Syros Pharmaceuticals, Inc. since Se...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Conley Chee
CEO, President & Directorless than a yearUS$1.04m0.46%
$ 277.5k
Richard Young
Scientific Founderno dataUS$82.15k0.040%
$ 24.2k
Jason Haas
Chief Financial Officer3.1yrsUS$833.02k0.46%
$ 282.1k
David Roth
Chief Medical Officer8.9yrsUS$876.53k0%
$ 0
James Bradner
Founderno datakeine Datenkeine Daten
Nathanael Gray
Scientific Founder & Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Karen Hunady
Director of Corporate Communications & Investor Relationsno datakeine Datenkeine Daten
Gerald Quirk
Chief Legal & Compliance Officer and Chief Business Officer2.1yrsUS$1.46m0.17%
$ 105.7k
Lisa Roberts
Vice President of Human Resources1.8yrskeine Datenkeine Daten
Kristin Stephens
Chief Development Officer4.4yrskeine Daten0.094%
$ 57.2k

2.6yrs

Durchschnittliche Betriebszugehörigkeit

56yo

Durchschnittliches Alter

Erfahrenes Management: SYRS's management team is considered experienced (2.6 years average tenure).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Conley Chee
CEO, President & Directorless than a yearUS$1.04m0.46%
$ 277.5k
Richard Young
Scientific Founder13yrsUS$82.15k0.040%
$ 24.2k
Nathanael Gray
Scientific Founder & Member of Scientific Advisory Board11.6yrskeine Datenkeine Daten
Peter Karl Wirth
Independent Chairman7.8yrsUS$110.40k0.060%
$ 36.2k
Mark Murcko
Member of Scientific Advisory Board11.6yrskeine Datenkeine Daten
Andrew Oh
Independent Director2.2yrsUS$78.53k0.060%
$ 36.2k
Nancy Simonian
Director11.6yrsUS$1.49m0.51%
$ 307.3k
Gerard Evan
Member of Scientific Advisory Board11.6yrskeine Datenkeine Daten
Scott Biller
Member of Scientific Advisory Board11.6yrskeine Datenkeine Daten
Bradley Bernstein
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Stefan Knapp
Member of Scientific Advisory Board11.6yrskeine Datenkeine Daten
Aviv Regev
Member of Scientific Advisory Board11.6yrskeine Datenkeine Daten

11.6yrs

Durchschnittliche Betriebszugehörigkeit

63.5yo

Durchschnittliches Alter

Erfahrener Vorstand: SYRS's board of directors are seasoned and experienced ( 11.6 years average tenure).